Ocular morbidity in patients on long-term selective serotonin reuptake inhibitors (SSRIs)

---

Original Article

Author Details : Pooja H V, H T Venkate Gowda, Rao Vaishnavi Prasad*

Volume : 7, Issue : 4, Year : 2021

Article Page : 364-367

https://doi.org/10.18231/j.ijooo.2021.076

Suggest article by email

Get Permission

---

Abstract

Purpose: To assess ocular morbidity in patients on long time anti-psychotic medication- SSRI.
Materials and Methods: Cross- sectional observational study was conducted on 96 patients on anti- psychotic medication (SSRI) who attended the OPD in Department of Ophthalmology and Psychiatry, from July 2019 to July 2021.
Results: Of 96 patients, 71(73.9%) patients had ocular morbidity. Most common ocular morbidities were dry eye 62 (87.3%) followed by, reduced corneal sensitivity 3(4.2%), cataract 3 (4.2%), glaucoma 2(2.8%), ischemic optic neuropathy 1 (1.4%).
Conclusion: Dry eye was the most common ocular morbidity seen. SSRIs on long term usage have significant ocular side effects, which should be kept in mind by both Ophthalmologists and Psychiatrics in their clinical practise.
 

Keywords: SSRI, Dry eye, Cataract, Glaucoma

How to cite : Pooja H V, Gowda H T V, Prasad R V, Ocular morbidity in patients on long-term selective serotonin reuptake inhibitors (SSRIs). IP Int J Ocul Oncol Oculoplasty 2021;7(4):364-367

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.